Clinical Trials Browser

Carcinoma, Neuroendocrine × sintilimab × Endocrine × Clear all

NCT05627427 2022-11-25

Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy

Phase 2 Unknown

EndocrineGastrointestinal

Pancreatic Neoplasms, Carcinoma, Neuroendocrine

NCT05113355 2021-11-24

Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm

Phase 2 Unknown

Carcinoma, Neuroendocrine, Neuroendocrine Tumors